These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23557396)

  • 21. [Serum markers in patients with idiopathic pulmonary alveolar proteinosis].
    Li Y; Tian X; Gui Y; Ma A; Li X; Zeng N; Zhang P; Li G; Xu K
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jul; 37(7):497-501. PubMed ID: 25262689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valuable Serum Markers in Pulmonary Alveolar Proteinosis.
    Shi S; Chen L; Qiu X; Zhao Q; Xiao Y; Yan X
    Dis Markers; 2019; 2019():9709531. PubMed ID: 31827650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking.
    Kobayashi H; Kanoh S; Motoyoshi K
    Biomarkers; 2008 Jun; 13(4):385-92. PubMed ID: 18595202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositis.
    Arai S; Kurasawa K; Maezawa R; Owada T; Okada H; Fukuda T
    Mod Rheumatol; 2013 Sep; 23(5):872-83. PubMed ID: 22983659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia.
    Yamakawa H; Hagiwara E; Ikeda S; Iwasawa T; Otoshi R; Tabata E; Okuda R; Sekine A; Baba T; Iso S; Okudela K; Takemura T; Ogura T
    Respir Investig; 2019 Sep; 57(5):422-429. PubMed ID: 31003951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the immunolocalization of surfactant protein (SP)-A, SP-D, and KL-6 in pulmonary alveolar proteinosis.
    Kobayashi M; Takeuchi T; Ohtsuki Y
    Pathol Int; 2008 Mar; 58(3):203-7. PubMed ID: 18251786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KL-6 concentration in pulmonary epithelial lining fluid is a useful prognostic indicator in patients with acute respiratory distress syndrome.
    Kondo T; Hattori N; Ishikawa N; Murai H; Haruta Y; Hirohashi N; Tanigawa K; Kohno N
    Respir Res; 2011 Mar; 12(1):32. PubMed ID: 21418654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of the modified lavage technique of Bingisser and KL-6 monitoring in a patient with pulmonary alveolar proteinosis.
    Ishikawa N; Kondo K; Oguri T; Kamitsuna M; Sakurai J; Fujitaka K; Yamasaki M; Maeda H; Isobe T; Kohno N
    Intern Med; 2002 May; 41(5):381-5. PubMed ID: 12058888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease.
    Ma H; Lu J; Song Y; Wang H; Yin S
    BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease.
    Ye Y; Fu Q; Wang R; Guo Q; Bao C
    J Clin Lab Anal; 2019 Oct; 33(8):e22978. PubMed ID: 31301087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Value of Biomarkers as Predictors of Outcome in Patients with Rheumatoid Arthritis-Associated Usual Interstitial Pneumonia.
    Lee YS; Kim HC; Lee BY; Lee CK; Kim MY; Jang SJ; Lee HS; Moon J; Colby TV; Kim DS
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):216-223. PubMed ID: 27758986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.
    Kennedy B; Branagan P; Moloney F; Haroon M; O'Connell OJ; O'Connor TM; O'Regan K; Harney S; Henry MT
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):228-36. PubMed ID: 26422568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis.
    Arai T; Inoue Y; Sugimoto C; Inoue Y; Nakao K; Takeuchi N; Matsumuro A; Hirose M; Nakata K; Hayashi S
    Respirology; 2014 Feb; 19(2):246-252. PubMed ID: 24251830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of myelodysplastic syndrome complicated by pulmonary alveolar proteinosis with a high serum KL-6 level.
    Kajiume T; Yoshimi S; Nagita A; Kobayashi K; Kataoka N; Nakajima M; Matsushima T
    Pediatr Hematol Oncol; 1999; 16(4):367-71. PubMed ID: 10407875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follow-up of serum KL-6 lung fibrosis biomarker levels in 173 patients with systemic sclerosis.
    Kumánovics G; Görbe E; Minier T; Simon D; Berki T; Czirják L
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-138-44. PubMed ID: 24773853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum KL-6 is associated with the severity of interstitial lung disease in Chinese patients with polymyositis and dermatomyositis.
    Hu C; Wu C; Yang E; Huang H; Xu D; Hou Y; Zhao J; Li M; Xu Z; Zeng X; Wang Q
    Clin Rheumatol; 2019 Aug; 38(8):2181-2187. PubMed ID: 30888566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum KL-6 as a novel disease marker in adolescent and adult cystic fibrosis.
    Ohshimo S; Bonella F; Grammann N; Starke K; Cui A; Bauer PC; Teschler H; Kohno N; Guzman J; Costabel U
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):47-53. PubMed ID: 19960788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of correlation between pulmonary function testing and high resolution computed tomography in pulmonary alveolar proteinosis].
    Chen QL; Shen J; Gao Y; Guan YB; An JY; Zheng JP
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jul; 31(7):505-8. PubMed ID: 19035229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum antibody against granulocyte/macrophage colony-stimulating factor and KL-6 in idiopathic pulmonary alveolar proteinosis.
    Nara M; Sano K; Ogawa H; Tamada T; Nagaoka M; Okada K; Watanabe M; Moriya T; Miki H; Nakata K; Ichinose M; Hattori T
    Tohoku J Exp Med; 2006 Apr; 208(4):349-54. PubMed ID: 16565598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.